Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets ![]() |
---|---|---|---|---|
Capital Group Central Cash Fund | Short Term | 56,069,838 | $5,606,423,129.00 | 5.79% |
Broadcom, Inc. | Equity | 3,686,331 | $3,061,792,802.00 | 3.16% |
Capital Group Central Corporate Bond Fund | Investment Fund | 291,627,376 | $2,312,605,089.00 | 2.39% |
Philip Morris International, Inc. | Equity | 23,345,152 | $2,161,294,172.00 | 2.23% |
AbbVie, Inc. | Equity | 13,827,970 | $2,061,197,208.00 | 2.13% |
Microsoft Corp. | Equity | 5,527,640 | $1,745,352,330.00 | 1.8% |
Zurich Insurance Group AG | Equity | 3,007,292 | $1,378,053,603.00 | 1.42% |
VICI Properties, Inc. REIT | Equity | 44,826,176 | $1,304,441,722.00 | 1.35% |
RTX Corp. | Equity | 17,234,410 | $1,240,360,488.00 | 1.28% |
Abbott Laboratories | Equity | 11,670,815 | $1,130,318,433.00 | 1.17% |
Canadian Natural Resources, Ltd. | Equity | 17,459,734 | $1,129,146,353.00 | 1.17% |
British American Tobacco PLC | Equity | 35,655,352 | $1,119,294,491.00 | 1.16% |
CME Group, Inc., Class A | Equity | 5,279,888 | $1,057,139,175.00 | 1.09% |
Amgen, Inc. | Equity | 3,877,670 | $1,042,162,589.00 | 1.08% |
Gilead Sciences, Inc. | Equity | 13,392,977 | $1,003,669,696.00 | 1.04% |